文献速递肺外科主动脉外科

直接阻断法切除侵犯主动脉弓或锁骨下动脉的肺癌

Direct Cross-Clamping for Resection of Lung Cancer Invading the Aortic Arch or the Subclavian Artery.
PubMed 文献 · Ann Thorac Surg · 2020-12-19

该研究回顾了9例肺癌侵犯主动脉弓或左锁骨下动脉的患者,采用不依赖体外循环的直接阻断技术行根治性切除。结果示无死亡,主要并发症率11.1%,中位生存20个月,结论认为该技术在选择患者中可行、安全、可靠。

要点

  • 直接阻断技术可作为体外循环的替代方案用于侵犯大血管的肺癌切除
  • 9例患者均实现完整切除,无死亡,主要并发症率11.1%
  • 中位随访17个月,复发率33.3%,中位生存20个月

核心结论

  • 直接阻断技术作为体外循环的替代方案,用于切除侵犯主动脉弓或锁骨下动脉的肺癌,在选择患者中可行、安全且可靠。

主要发现

  • 患者平均年龄64.7±13.3岁(范围36至78岁)。
  • 主动脉弓切除均为部分性(外膜1例,全层4例);左锁骨下动脉切除外膜2例,环周2例;所有切除均完整。
  • 4例接受人工血管重建;平均手术时间130±25.6分钟;平均血管阻断时间28.2±3.2分钟。
  • 无死亡发生;主要并发症率为11.1%。
  • 平均随访17±9个月(范围5至29个月),复发率33.3%,中位生存20个月。

临床怎么用

  • 对于选择性的侵犯主动脉弓或左锁骨下动脉的肺癌患者,可考虑采用不依赖体外循环的直接阻断技术行根治性切除。

局限性

  • 样本量小(9例),为单中心回顾性经验,随访时间有限(平均17个月),结论需谨慎推广。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Resection of lung cancer infiltrating the aortic arch or the subclavian artery can be accomplished in selected patients with the use of cardiopulmonary bypass (CPB). Direct cross-clamping of the aortic arch and the left subclavian artery without CPB for radical resection of the tumor can be an alternative. This study presents one group's experience with this technique. METHODS: Between October 2016 and May 2019, 9 patients (5 male, 4 female) underwent radical resection of lung cancer infiltrating the aortic arch (n = 5) or the left subclavian artery (n = 4) by direct cross-clamping technique at Sapienza University of Rome, Italy. Seven left upper lobectomies, 1 left pneumonectomy, and 1 left upper sleeve lobectomy were performed. Reconstruction of the aortic arch was performed by direct suturing or polyethylene terephthalate (Dacron) patch, whereas the subclavian artery was reconstructed with a Dacron conduit. Three patients received neoadjuvant chemotherapy. RESULTS: Patients' mean age was 64.7 ± 13.3 years (range, 36 to 78 years). Aortic arch resection was partial in all cases (adventitial in 1 and full thickness in 4); left subclavian artery resection was adventitial in 2 patients and circumferential in 2. All the resections were complete. Prosthetic reconstruction was performed in 4 cases. Mean operative time was 130 ± 25.6 minutes; mean vascular clamping time was 28.2 ± 3.2 minutes. No mortality occurred. The major complication rate was 11.1 %. At a mean follow-up of 17 ± 9 months (range, 5 to 29 months), the recurrence rate was 33.3%. Median survival was 20 months. CONCLUSIONS: Direct cross-clamping as an alternative to CPB for resection of lung cancer infiltrating the aortic arch or the subclavian artery is a feasible, safe, and reliable procedure in selected patients.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Maurizi G, D'Andrilli A, Vanni C, et al. Direct Cross-Clamping for Resection of Lung Cancer Invading the Aortic Arch or the Subclavian Artery. Ann Thorac Surg. 2020. PMID: 33352179. doi:10.1016/j.athoracsur.2020.12.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。